Claire Mazumdar - Jun 9, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Director
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Jun 9, 2025
Transactions value $
$0
Form type
4
Date filed
6/11/2025, 04:16 PM
Previous filing
Sep 12, 2024
Next filing
Oct 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mazumdar Claire Director C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Brian Adams, as Attorney-in-Fact 2025-06-11 0002034671

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Award $0 +421K $0.00 421K Jun 9, 2025 Common Stock 421K $3.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments after June 9, 2025, subject to the reporting person's continued service with the Issuer through each vesting date.